1. Motzer R.J., Memorial Sloan Kettering Cancer Center Þ, Jonasch E., et al. NCCN Guidelines Version 4.2022 Kidney Cancer Continue NCCN Guidelines Panel Disclosures.; 2021. 〈https://www.nccn.org/home/member-〉.
2. Gupta S., Weiss J.M., Burke C.A., et al. NCCN Guidelines Version 2.2021 Genetic/Familial High-Risk Assessment: Colorectal Continue.; 2022. 〈https://www.nccn.org/home/〉.
3. Dwyer, Mary. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ®) Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic.; 2023. 〈https://www.nccn.org/home/member〉-.
4. Genetic information, non-discrimination, and privacy protections in genetic counseling practice;Prince;J Genet Couns,2014
5. Cascade testing for hereditary cancer syndromes: should we move toward direct relative contact? A systematic review and meta-analysis;Frey;J Clin Oncol,2022